Yes, wild-type and hereditary ATTR amyloidosis can be treated with some of the same medications. Here are the details:

- Tafamidis (Vyndamax and Vyndaqel): Approved by the FDA to treat heart disease in both wild-type and hereditary ATTR amyloidosis. These drugs work by stopping the TTR protein from forming amyloid fibrils Show Full Answer

Yes, wild-type and hereditary ATTR amyloidosis can be treated with some of the same medications. Here are the details:

- Tafamidis (Vyndamax and Vyndaqel): Approved by the FDA to treat heart disease in both wild-type and hereditary ATTR amyloidosis. These drugs work by stopping the TTR protein from forming amyloid fibrils.
- Diflunisal: Although not officially approved for amyloidosis, it is sometimes prescribed off-label for both types.

Additionally, gene-silencing therapies approved for hereditary ATTR amyloidosis are being studied for their potential use in treating wild-type amyloidosis.

 This AI-generated response comes from MyAmyloidosisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Wild-Type Amyloidosis — An Overview | MyAmyloidosisTeam

hATTR Amyloidosis Treatments: Comparing Your Options | MyAmyloidosisTeam